Population-based hormone receptor-specific incidence trends of breast cancer in Germany

Maturitas

Volumn 73, Issue 2, 2012, Pages 152-157

  Rusner, Carsten ^a   Bandemer Greulich, Ulrike ^b   Engel, Jutta ^c   Stegmaier, Christa ^d   Zawinell, Anette ^e   Holleczek, Bernd ^d   Katalinic, Alexander ^f   Kuss, Oliver ^a   Schmidt Pokrzywniak, Andrea ^a   Schubert Fritschle, Gabriele ^c   Tillack, Anett ^b   Stang, Andreas ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b Cancer Registry of the Federal State of Brandenburg   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d SAARLAND CANCER REGISTRY   (Germany)

^e Wissenschaftliches Institut der AOK WIdO   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Breast cancer; Cancer registry; Estrogen receptors; Hormone replacement therapy; Incidence; Progesterone receptors

Indexed keywords

ESTROGEN RECEPTOR;

AGED; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; ESTROGEN THERAPY; FEMALE; GERMANY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; METABOLISM; MIDDLE AGED;

AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 84873957677     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.06.008     Document Type: Article

References (32)

1. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women - principal results from the Women's Health Initiative randomized controlled trial JAMA-Journal of the American Medical Association 288 3 2002 321 333
2. E. Banks, V. Beral, and D. Bull Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 2003 419 427
3. P.M. Ravdin, K.A. Cronin, and N. Howlader The decrease in breast-cancer incidence in 2003 in the United States New England Journal of Medicine 356 16 2007 1670 1674
4. C. McNeil Breast cancer decline mirrors fall in hormone use, spurs both debate and research Journal of the National Cancer Institute 99 4 2007 266 267
5. E.V. Kliewer, A.A. Demers, and Z.J. Nugent A decline in breast-cancer incidence New England Journal of Medicine 357 5 2007 509 510
6. K. Canfell, E. Banks, A.M. Moa, and V. Beral Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia Medical Journal of Australia 188 11 2008 641 644
7. E. Hemminki, P. Kyyronen, and E. Pukkala Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005 Maturitas 61 4 2008 299 304
8. A. Katalinic, A. Lemmer, A. Zawinell, R. Rawal, and A. Waldmann Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries Pathobiology 76 2 2009 90 97
9. D.M. Parkin Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? European Journal of Cancer 45 9 2009 1649 1653
10. P. De, C.I. Neutel, I. Olivotto, and H. Morrison Breast cancer incidence and hormone replacement therapy in Canada Journal of the National Cancer Institute 102 19 2010 1489 1495
11. K.A. Cronin, P.M. Ravdin, and B.K. Edwards Sustained lower rates of breast cancer in the United States Breast Cancer Research and Treatment 117 1 2009 223 224
12. A.M. Fontenoy, C. Leux, and S. Delacour-Billon Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003 Cancer Epidemiology 34 3 2010 238 243
13. K.H. Sharpe, P. McClements, D.I. Clark, J. Collins, A. Springbett, and D.H. Brewster Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy European Journal of Cancer 46 5 2010 937 943
14. M.P. Curado, B. Edwards, and H.R. Shin Cancer in five continents vol. IX 2007 IARC Press Lyon
15. World Health Organization. The International Statistical Classification of Diseases and Related Health Problems, Tenth revision. Geneva; 1992.
16. International Agency for Research on Cancer International Rules for Coding Multiple Primary cancers (ICD-O third edition) 2004 IARC Press Lyon
17. M.A. Klebanoff, and S.R. Cole Use of multiple imputation in the epidemiologic literature American Journal of Epidemiology 168 4 2008 355 357
18. K.J.M. Janssen, A.R.T. Donders, and F.E. Harrell Missing covariate data in medical research: to impute is better than to ignore Journal of Clinical Epidemiology 63 7 2010 721 727
19. R.J.A. Little, and D.B. Rubin Statistical analysis with missing data second edition 2002 John Wiley & Sons New York
20. Wissenschaftliches Institut der AOK. Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen. Amtliche Fassung des ATC-Index mit DDD-Angaben für Deutschland im Jahre 2009. Berlin; 2009.
21. J. Estève, E. Bendhamon, and L. Raymond Statistical methods in cancer research 1994 IARC Press Lyon
22. P. Vankrunkelsven, E. Kellen, and D. Lousbergh Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg Breast Cancer Research and Treatment 118 2 2009 425 432
23. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA-Journal of the American Medical Association 280 7 1998 605 613
24. M. Dietel Hormone replacement therapy (HRT), breast cancer and tumor pathology Maturitas 65 3 2010 183 189
25. A. Hsu, A. Card, S.X. Lin, S. Mota, O. Carrasquillo, and A. Moran Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk American Journal of Public Health 99 12 2009 2184 2187
26. A.L. Hersh, M.L. Stefanick, and R.S. Stafford National use of postmenopausal hormone therapy: annual trends and response to recent evidence JAMA-Journal of the American Medical Association 91 1 2004 47 53
27. U. Schwabe, and D. Pfaffrath Arzneiverordnungs-Report 2000 2000 Springer Berlin
28. U. Schwabe, and D. Pfaffrath Arzneiverordnungs-Report 2002 2002 Springer Berlin
29. U. Schwabe, and D. Pfaffrath Arzneiverordnungs-Report 2004 2004 Springer Berlin
30. Kooperationsgemeinschaft Mammographie. Evaluationsbericht 2005-2007. Ergebnisse des Mammographie-Screening-Programms in Deutschland. Berlin; 2009.
31. M. Sluyser, and J.L. Wittliff Influence of estrogen-receptor variants in mammary carcinomas on the prognostic reliability of the receptor assay Molecular and Cellular Endocrinology 85 1-2 1992 83 88
32. A. Rhodes, B. Jasani, D.M. Barnes, L.G. Bobrow, and K.D. Miller Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems Journal of Clinical Pathology 53 2 2000 125 130